TY - JOUR T1 - One Shot Model For COVID-19 Classification and Lesions Segmentation In Chest CT Scans Using LSTM With Attention Mechanism JF - medRxiv DO - 10.1101/2021.02.16.21251754 SP - 2021.02.16.21251754 AU - Aram Ter-Sarkisov Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/02/19/2021.02.16.21251754.abstract N2 - We present a model that fuses instance segmentation, Long Short-Term Memory Network and Attention mechanism to predict COVID-19 and segment chest CT scans. The model works by extracting a sequence of Regions of Interest that contain class-relevant information, and applies two Long Short-Term Memory networks with attention to this sequence to extract class-relevant features. The model is trained in one shot: both segmentation and classification branches, using two different sets of data. We achieve a 95.74% COVID-19 sensitivity, 98.13% Common Pneumonia sensitivity, 99.27% Control sensitivity and 98.15% class-adjusted F1 score on the main dataset of 21191 chest CT scan slices, and also run a number of ablation studies in which we achieve 97.73% COVID-19 sensitivity and 98.41% F1 score. All source code and models are available on https://github.com/AlexTS1980/COVID-LSTM-Attention.Competing Interest StatementThe authors have declared no competing interest.Funding StatementN/AAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is referenced in the text and is publicly available ER -